KKR to pay $150 mln for stake in Indian pharmaceutical company

Private equity firm KKR & Co LP will pay about $150 million for close to 30 percent of India's Gland Pharma Ltd, two sources with direct knowledge of the matter said, in what would be the U.S. buyout firm's eighth investment in Asia this year.

DealsNorth AmericaUSBriefs